Teva Pharmaceuticals Financial Statements
Teva Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Teva Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 9,408.0 | 8,408.0 | 5,250.4 |
| Gross Profit ($ mil.) | 4,877.0 | 4,259.0 | 2,480.6 |
| Operating Income ($ mil.) | 2,395.0 | 801.0 | 1,312.9 |
| Total Net Income ($ mil.) | 1,952.0 | 546.0 | 1,072.3 |
| Diluted EPS (Net Income) | -- | -- | 1.59 |
Teva Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.03 | 3.50 | 1.54 |
| Price/Earnings Ratio | -- | 15.38 | 15.76 |
| Price/Book Ratio | 2.08 | 2.94 | 1.49 |
| Price/Cash Flow Ratio | 15.73 | 12.49 | 9.63 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Teva Pharmaceuticals Financial Ratios
Teva Pharmaceuticals Competitive Intelligence
| Barr Pharmaceuticals | Sandoz International GmbH | Watson Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2,500.6 | 3,045.0 | 2,496.6 |
| Employees | 8,900 | 13,397 | 56,400 |
| Market Cap ($ mil.) | 7,377.1 | -- | 3,159.6 |
Competitive Landscape
